Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2014

Jan 29, 2014

33819_dirs_2014-01-29_aa9023a3-028b-4f9f-8240-5a99502f6d40.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2014-01-27

Reporting Person: Stratton Kenneth Blair (General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-27 Common Stock F 11921 $1.41 Disposed 407734 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 16523 Indirect

Footnotes

F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by him from the delivery of shares incident to the vesting of restricted stock units.

F2: Includes (1) 280,000 restricted stock units, with 70,000 of this vesting on each of May 24, 2014, May 24, 2015, May 24, 2016, and May 24, 2017; (2) 65,000 restricted stock units, with 32,500 of this vesting on each of January 27, 2015 and January 27, 2016; and (3) 5,000 restricted stock units vesting on June 1, 2014.

F3: Includes shares held in 401(k) account in accordance with issuer's employer-match policies.